Tamsin Lannagan
Grant-Funded Researcher (B)
South Australian Immunogenomics Cancer Institute
Faculty of Health and Medical Sciences
Eligible to supervise Masters and PhD (as Co-Supervisor) - email supervisor to discuss availability.
Senior Postdoctoral Researcher and Ainsworth Fellow in T Cell Immunotherapy Laboratory (SAiGENCI).Dr Lannagan completed her PhD at the University of Edinburgh in Scotland in 2009 and has spent the last 13 years working with mouse models of cancer in Australia at CSIRO and SAHMRI (with Dan Worthley and Susan Woods) and in Scotland at the CRUK Scotland Institute (with Owen Sansom). Her areas of expertise have been in characterising KRAS genetically engineered mouse models (GEMMS) of early and metastatic colorectal cancer using sequencing technologies, looking at the tumour microenvironment as well as investigating stem cell plasticity. She has used complex GEMMS, generated in vitro tumour organoids and has used these to develop surgical and transplant models of metastatic cancer. These models were aligned to patient disease subtypes and she ran trials using mouse cancer models to test novel therapeutics. Dr Lannagan returned to Adelaide in 2024 to work under Dr Mara Zeissig in the T Cell Immunotherapy Lab at SAiGENCI.
Dr Lannagan is working on improving responses to T-cell based immunotherapies in solid cancers, with a focus on lung and pancreatic cancers. The lab uses a range of approaches, including genetically engineered mouse models and sophisticated CRISPR-Cas9 genetic screening techniques to understand how tumours evade the immune system and identify immune modulators to increase the efficacy of immunotherapy in solid tumours.
| Date | Position | Institution name |
|---|---|---|
| 2024 - ongoing | Senior Postdoctoral Researcher | Ainsworth Research Fellow | University of Adelaide |
| 2021 - 2024 | Principal Scientific Officer | Cancer Research UK Beatson Institute |
| 2019 - 2021 | Postdoctoral Researcher | Cancer Research UK Beatson Institute |
| 2015 - 2018 | Postdoctoral Researcher | University of Adelaide |
| 2011 - 2014 | Office of the Chief Executive Postdoctoral Fellow | Commonwealth Scientific and Industrial Research Organisation |
| 2009 - 2011 | Career Development Fellow | Medical Research Council |
| Date | Institution name | Country | Title |
|---|---|---|---|
| 2004 - 2009 | University of Edinburgh | United Kingdom | PhD |
| 1999 - 2003 | University of Edinburgh | United Kingdom | BSc |
| Year | Citation |
|---|---|
| 2025 | Mzoughi, S., Schwarz, M., Wang, X., Demircioglu, D., Ulukaya, G., Mohammed, K., . . . Guccione, E. (2025). Oncofetal reprogramming drives phenotypic plasticity in WNT-dependent colorectal cancer. Nature Genetics, 57(2), 402-412. Scopus15 WoS15 Europe PMC17 |
| 2025 | Fetit, R., McLaren, A. S., White, M., Mills, M. L., Falconer, J., Cortes-Lavaud, X., . . . Steele, C. W. (2025). Erratum: Correction: Characterizing Neutrophil Subtypes in Cancer Using scRNA Sequencing Demonstrates the Importance of IL1β/CXCR2 Axis in Generation of Metastasis-Specific Neutrophils (Cancer research communications (2024) 4 2 DOI: 10.1158/2767-9764.CRC-23-0319.). Cancer research communications, 5(4), 609. |
| 2025 | Harryvan, T. J., Abudukelimu, S., Stouten, I., van der Wel, E. J., Janson, S. G. T., Lenos, K. J., . . . Hawinkels, L. J. A. C. (2025). TGFβ signaling in cancer-associated fibroblasts drives a hepatic gp130-dependent pro-metastatic inflammatory program in colorectal cancer. Iscience, 28(11), 113696. |
| 2025 | Torang, A., Kirov, A. B., Lammers, V., Cameron, K., Wouters, V. M., Jackstadt, R. F., . . . Medema, J. P. (2025). Enterocyte-like differentiation defines metabolic gene signatures of CMS3 colorectal cancers and provides therapeutic vulnerability. Nature Communications, 16(1), 16 pages. Scopus3 WoS3 Europe PMC3 |
| 2025 | White, M., Mills, M. L., Millett, L. M., Gilroy, K., Hong, Y., Zeiger, L. B., . . . Sansom, O. J. (2025). MAPK-driven epithelial cell plasticity drives colorectal cancer therapeutic resistance.. Nature. |
| 2024 | Fetit, R., McLaren, A. S., White, M., Mills, M. L., Falconer, J., Cortes-Lavaud, X., . . . Steele, C. W. (2024). Characterizing Neutrophil Subtypes in Cancer Using scRNA Sequencing Demonstrates the Importance of IL1β/CXCR2 Axis in Generation of Metastasis-specific Neutrophils. Cancer research communications, 4(2), 588-606. Scopus7 WoS8 Europe PMC7 |
| 2024 | Loi, P., Schade, A. E., Rodriguez, C. L., Krishnan, A., Perurena, N., Nguyen, V. T. M., . . . Cichowski, K. (2024). Epigenetic and Oncogenic Inhibitors Cooperatively Drive Differentiation and Kill KRAS-Mutant Colorectal Cancers. Cancer Discovery, 14(12), 2430-2449. Scopus3 WoS2 Europe PMC6 |
| 2024 | Malviya, G., Lannagan, T., Johnson, E., Mackintosh, A., Bielik, R., Peters, A., . . . Lewis, D. (2024). Noninvasive Stratification of Colon Cancer by Multiplex PET Imaging. CLINICAL CANCER RESEARCH, 30(8), 1518-1529. WoS3 Europe PMC3 |
| 2024 | Gurbatri, C. R., Radford, G. A., Vrbanac, L., Im, J., Thomas, E. M., Coker, C., . . . Danino, T. (2024). Engineering tumor-colonizing E. coli Nissle 1917 for detection and treatment of colorectal neoplasia. Nature Communications, 15(646), 646-1-646-13. Scopus94 WoS89 Europe PMC73 |
| 2024 | Malla, S. B., Byrne, R. M., Lafarge, M. W., Corry, S. M., Fisher, N. C., Tsantoulis, P. K., . . . Dunne, P. D. (2024). Correction to: Pathway level subtyping identifies a slow-cycling biological phenotype associated with poor clinical outcomes in colorectal cancer (Nature Genetics, (2024), 56, 3, (458-472), 10.1038/s41588-024-01654-5). Nature Genetics, 56(6), 1321. Scopus2 WoS1 |
| 2024 | Malviya, G., Lannagan, T. R. M., Johnson, E., Mackintosh, A., Bielik, R., Peters, A., . . . Lewis, D. Y. (2024). Noninvasive Stratification of Colon Cancer by Multiplex PET Imaging. Clinical Cancer Research, 30(8), 1518-1529. Scopus2 |
| 2024 | Nair, R., Lannagan, T. R. M., Jackstadt, R., Andrusaite, A., Cole, J., Boyne, C., . . . Milling, S. (2024). Co-inhibition of TGF-β and PD-L1 pathways in a metastatic colorectal cancer mouse model triggers interferon responses, innate cells and T cells, alongside metabolic changes and tumor resistance. OncoImmunology, 13(1). Scopus5 |
| 2024 | Pennel, K. A. F., Hatthakarnkul, P., Wood, C. S., Lian, G. Y., Al-Badran, S. S. F., Quinn, J. A., . . . Edwards, J. (2024). JAK/STAT3 represents a therapeutic target for colorectal cancer patients with stromal-rich tumors. Journal of Experimental and Clinical Cancer Research, 43(1). Scopus24 |
| 2024 | Malla, S. B., Byrne, R. M., Lafarge, M. W., Corry, S. M., Fisher, N. C., Tsantoulis, P. K., . . . Dunne, P. D. (2024). Pathway level subtyping identifies a slow-cycling biological phenotype associated with poor clinical outcomes in colorectal cancer. Nature Genetics, 56(3), 458-472. Scopus27 |
| 2023 | Vande Voorde, J., Steven, R. T., Najumudeen, A. K., Ford, C. A., Dexter, A., Gonzalez-Fernandez, A., . . . Sansom, O. J. (2023). Metabolic profiling stratifies colorectal cancer and reveals adenosylhomocysteinase as a therapeutic target. Nature Metabolism, 5(8), 1303-1318. Scopus38 |
| 2023 | Amirkhah, R., Gilroy, K., Malla, S. B., Lannagan, T. R. M., Byrne, R. M., Fisher, N. C., . . . Dunne, P. D. (2023). MmCMS: mouse models’ consensus molecular subtypes of colorectal cancer. British Journal of Cancer, 128(7), 1333-1343. Scopus15 |
| 2023 | Ng, J. Q., Jafarov, T. H., Little, C. B., Wang, T., Ali, A. M., Ma, Y., . . . Mukherjee, S. (2023). Loss of Grem1-lineage chondrogenic progenitor cells causes osteoarthritis. Nature Communications, 14(1), 6909-1-6909-14. Scopus28 WoS26 Europe PMC26 |
| 2022 | Kobayashi, H., Gieniec, K. A., Lannagan, T. R., Wang, T., Asai, N., Mizutani, Y., . . . Worthley, D. L. (2022). The origin and contribution of cancer-associated fibroblasts in colorectal carcinogenesis. Gastroenterology, 162(3), 890-906. Scopus142 WoS151 Europe PMC135 |
| 2022 | Gil Vazquez, E., Nasreddin, N., Valbuena, G. N., Mulholland, E. J., Belnoue-Davis, H. L., Eggington, H. R., . . . Leedham, S. J. (2022). Erratum: Dynamic and adaptive cancer stem cell population admixture in colorectal neoplasia (Cell Stem Cell (2022) 29(8) (1213–1228.e8), (S1934590922003034), (10.1016/j.stem.2022.07.008)). Cell Stem Cell, 29(11), 1612. Scopus5 |
| 2022 | Freckmann, E. C., Sandilands, E., Cumming, E., Neilson, M., Román-Fernández, A., Nikolatou, K., . . . Bryant, D. M. (2022). Traject3d allows label-free identification of distinct co-occurring phenotypes within 3D culture by live imaging. Nature Communications, 13(1). Scopus16 |
| 2022 | Vasquez, E. G., Nasreddin, N., Valbuena, G. N., Mulholland, E. J., Belnoue-Davis, H. L., Eggington, H. R., . . . Leedham, S. J. (2022). Dynamic and adaptive cancer stem cell population admixture in colorectal neoplasia. Cell Stem Cell, 29(8), 1213-1228.e8. Scopus65 Europe PMC71 |
| 2022 | Corry, S. M., Mccorry, A. M. B., Lannagan, T. R. M., Leonard, N. A., Fisher, N. C., Byrne, R. M., . . . Dunne, P. D. (2022). Activation of innate-adaptive immune machinery by poly(I:C) exposes a therapeutic vulnerability to prevent relapse in stroma-rich colon cancer. Gut, 71(12), 2502-2517. Scopus14 WoS14 |
| 2022 | Ahmaderaghi, B., Amirkhah, R., Jackson, J., Lannagan, T. R. M., Gilroy, K., Malla, S. B., . . . Dunne, P. D. (2022). Molecular Subtyping Resource: a user-friendly tool for rapid biological discovery from transcriptional data. DMM Disease Models and Mechanisms, 15(3). Scopus4 |
| 2021 | Gillespie, M. A., Steele, C. W., Lannagan, T. R. M., Sansom, O. J., & Roxburgh, C. S. D. (2021). Pre-clinical modelling of rectal cancer to develop novel radiotherapy-based treatment strategies. Oncology Reviews, 15(1), 8 pages. Scopus5 WoS5 Europe PMC4 |
| 2021 | Krotenberg Garcia, A., Fumagalli, A., Le, H. Q., Jackstadt, R., Lannagan, T. R. M., Sansom, O. J., . . . Suijkerbuijk, S. J. E. (2021). Active elimination of intestinal cells drives oncogenic growth in organoids. Cell Reports, 36(1), 18 pages. Scopus26 WoS25 |
| 2021 | Ramesh, P., Lannagan, T. R. M., Jackstadt, R., Atencia Taboada, L., Lansu, N., Wirapati, P., . . . Medema, J. P. (2021). BCL-XL is crucial for progression through the adenoma-to-carcinoma sequence of colorectal cancer. Cell Death and Differentiation, 28(12), 3282-3296. Scopus46 |
| 2021 | Lannagan, T. R., Jackstadt, R., Leedham, S. J., & Sansom, O. J. (2021). Advances in colon cancer research: in vitro and animal models. Current Opinion in Genetics and Development, 66, 50-56. Scopus58 |
| 2021 | Ichinose, M., Suzuki, N., Wang, T., Wright, J. A., Lannagan, T. R. M., Vrbanac, L., . . . Woods, S. L. (2021). Delineating proinflammatory microenvironmental signals by ex vivo modeling of the immature intestinal stroma. Scientific Reports, 11(1), 7200-1-7200-11. Scopus2 WoS2 Europe PMC2 |
| 2021 | Suzuki, M., Suzuki, N., Wang, T., Kobayashi, H., Vrbanac, L., Ng, J. Q., . . . Woods, S. L. (2021). The BMP antagonist Gremlin1 contributes to the development of cortical excitatory neurons, motor balance and fear responses. Development, 148(14), dev195883-1-dev195883-15. Scopus8 WoS8 Europe PMC8 |
| 2021 | Kobayashi, H., Gieniec, K. A., Ng, J. Q., Goyne, J., Lannagan, T. R. M., Thomas, E. M., . . . Woods, S. L. (2021). Portal Vein Injection of Colorectal Cancer Organoids to Study the Liver Metastasis Stroma. Journal of Visualized Experiments, 2021(175), e62630-1-e62630-21. Scopus2 WoS2 Europe PMC3 |
| 2021 | Suzuki, M. I., Suzuki, N., Wang, T., Wright, J. A., Lannagan, T. R., Vrbanac, L., . . . Woods, S. L. (2021). Stromal DLK1 promotes proliferation and inhibits differentiation of the intestinal epithelium during development. American Journal of Physiology: Gastrointestinal and Liver Physiology, 320(4), G506-G520. Scopus6 WoS5 Europe PMC5 |
| 2020 | Narasimhan, V., Wright, J. A., Churchill, M., Wang, T., Rosati, R., Lannagan, T. R., . . . Woods, S. L. (2020). Medium-throughput drug screening of patient-derived organoids from colorectal peritoneal metastases to direct personalized therapy. Clinical Cancer Research, 26(14), 1-26. Scopus154 WoS136 Europe PMC135 |
| 2020 | Kobayashi, H., Gieniec, K. A., Wright, J. A., Wang, T., Asai, N., Mizutani, Y., . . . Woods, S. L. (2020). The Balance of stromal BMP signaling mediated by GREM1 and ISLR drives colorectal carcinogenesis. Gastroenterology, 160(4), 1224-1239. Scopus121 WoS118 Europe PMC123 |
| 2019 | Lannagan, T. R. M., Lee, Y. K., Wang, T., Roper, J., Bettington, M. L., Fennell, L., . . . Woods, S. L. (2019). Genetic editing of colonic organoids provides a molecularly distinct and orthotopic preclinical model of serrated carcinogenesis. Gut, 68(4), 684-692. Scopus97 WoS95 Europe PMC95 |
| 2019 | Kleeman, S. O., Koelzer, V. H., Jones, H. J., Vazquez, E. G., Davis, H., East, J. E., . . . Leedham, S. J. (2019). Exploiting differential Wnt target gene expression to generate a molecular biomarker for colorectal cancer stratification. Gut, 69(6), 1092-1103. Scopus56 WoS54 Europe PMC55 |
| 2018 | Bond, C., Liu, C., Kawamata, F., McKeone, D., Fernando, W., Jamieson, S., . . . Whitehall, V. (2018). Oncogenic BRAF mutation induces DNA methylation changes in a murine model for human serrated colorectal neoplasia. Epigenetics, 13(1), 40-48. Scopus53 WoS49 Europe PMC42 |
| 2017 | Lannagan, T., Lee, Y., Somashekar, R., Wang, T., Vrbanac, L., Ng, J., . . . Woods, S. (2017). GENETIC EDITING OF COLONIC ORGANOIDS PROVIDES A MOLECULARLY DISTINCT AND ORTHOTOPIC MOUSE MODEL OF SERRATED CARCINOGENESIS. GASTROENTEROLOGY, 152(5), S103. |
| 2016 | Li, J., Woods, S., Healey, S., Beesley, J., Chen, X., Lee, J., . . . Schrader, K. (2016). Point mutations in Exon 1B of APC reveal gastric adenocarcinoma and proximal polyposis of the stomach as a familial adenomatous polyposis variant. American Journal of Human Genetics, 98(5), 830-842. Scopus205 WoS159 Europe PMC149 |
| 2016 | Le Leu, R., Scherer, B., Mano, M., Winter, J., Lannagan, T., Head, R., . . . Clarke, J. (2016). Dietary butyrylated high-amylose starch reduces azoxymethane-induced colonic O⁶ -methylguanine adducts in rats as measured by immunohistochemistry and high-pressure liquid chromatography. Nutrition Research, 36(9), 982-988. Scopus9 WoS9 Europe PMC9 |
| 2013 | Lannagan, T., Wilson, M., Denison, F., Norman, J., Catalano, R., & Jabbour, H. (2013). Prokineticin 1 induces a pro-inflammatory response in murine fetal membranes but does not induce preterm delivery. Reproduction, 146(6), 581-591. Scopus5 WoS4 Europe PMC5 |
| 2010 | Catalano, R. D., Lannagan, T. R. M., Gorowiec, M., Denison, F. C., Norman, J. E., & Jabbour, H. N. (2010). Prokineticins: novel mediators of inflammatory and contractile pathways at parturition?. Molecular Human Reproduction, 16(5), 311-319. Scopus34 WoS32 Europe PMC31 |
| 2009 | Filis, P., Lannagan, T., Thomson, A., Murray, A. A., Kind, P. C., & Spears, N. (2009). Phospholipase C-β1 signaling affects reproductive behavior, ovulation, and implantation. Endocrinology, 150(7), 3259-3266. Scopus8 WoS7 Europe PMC6 |
| Year | Citation |
|---|---|
| 2025 | Melissourgou-Syka, L., Gillespie, M. A., Hillson, L. V. S., Gilroy, K., Stevenson, K., Susanti, S., . . . Roxburgh, C. S. D. (2025). Investigating the role of the tumor microenvironment in the rectal cancer response to preclinical radio-immunotherapy combinations. In CLINICAL CANCER RESEARCH Vol. 31 (pp. 3 pages). CA, San Diego: AMER ASSOC CANCER RESEARCH. |
| 2024 | Melissourgou-Syka, L., Gillespie, M. A., Stevenson, K., Lannagan, T. R. M., O'Cathail, S. M., Steele, C. W., . . . Roxburgh, C. S. D. (2024). The Role of the Tumour Niche on Radiation Response in a Murine Model of Rectal Cancer. In RADIOTHERAPY AND ONCOLOGY Vol. 194 (pp. S5341-S5342). ENGLAND, Glasgow: ELSEVIER IRELAND LTD. |
| 2024 | McLaren, A. S., Fetit, R., White, M., Mills, M. L., Lannagan, T., Falconer, J., . . . Steele, C. W. (2024). Single cell RNA sequencing of human and murine cancers demonstrates metastases-specific neutrophil phenotypes driven by the IL-1β/CXCR2 signaling axis - Disruption of this pathway abrogates neutrophil immunosuppressive effects and reduces tumor burden. In CANCER RESEARCH Vol. 84 (pp. 2 pages). CA, San Diego: AMER ASSOC CANCER RESEARCH. DOI |
| 2023 | White, M., Lannagan, T., McGarry, L., Carlin, L., Mills, M., Yazgili, A. S., . . . Sansom, O. J. (2023). Pre-clinical modelling and treatment of BRAF mutated colorectal cancer. In ANNALS OF ONCOLOGY Vol. 34 (pp. S195). SPAIN, Madrid: ELSEVIER. DOI |
| 2022 | White, M., Tsantoulis, P., Lannagan, T., Najumudeen, A., Ridgeway, R. A., Campbell, A. D., . . . Sansom, O. J. (2022). NOTCH1 driven metastasis in BRAF mutated colorectal cancer. In ANNALS OF ONCOLOGY Vol. 33 (pp. S554). ELECTR NETWORK: ELSEVIER. DOI |
| 2022 | Gan, H., White, M., McGaffin, G., Lannagan, T., Campbell, A., Graham, J., . . . Wilson, R. (2022). Real-world outcomes in BRAFV600E metastatic colorectal cancer - the Glasgow experience. In ANNALS OF ONCOLOGY Vol. 33 (pp. S259-S260). SPAIN, Barcelona: ELSEVIER. DOI |
| 2020 | Suzuki, N., Wright, J., Kobayashi, H., Wang, T., Ichinose, M., Vrbanac, L., . . . Worthley, D. (2020). Generation of a mouse model of gastric adenocarcinoma and proximal polyposis of the stomach that causes stomach hyperplasia. In JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY Vol. 35 (pp. 165). WILEY. |
| 2020 | Kobayashi, H., Gieniec, K., Lannagan, T., Wang, T., Asfaha, S., Hayakawa, Y., . . . Worthley, D. (2020). THE ORIGIN AND FUNCTION OF CANCER-ASSOCIATED FIBROBLASTS IN COLORECTAL CARCINOGENESIS. In GASTROENTEROLOGY Vol. 158 (pp. S160). TX, Austin: W B SAUNDERS CO-ELSEVIER INC. |
| 2020 | Suzuki, N., Wright, J., Kobayashi, H., Wang, T., Ichinose, M., Vrbanac, L., . . . Worthley, D. (2020). GENERATION OF A GASTRIC ADENOCARCINOMA AND PROXIMAL POLYPOSIS OF THE STOMACH (GAPPS) MOUSE THAT PHENOCOPIES HUMAN DISEASE. In GASTROENTEROLOGY Vol. 158 (pp. S160). TX, Austin: W B SAUNDERS CO-ELSEVIER INC. |
| 2020 | Ichinose, M., Suzuki, N., Wang, T., Wright, J., Vrbanac, L., Lannagan, T., . . . Worthley, D. (2020). STROMAL DLK1 PROMOTES EPITHELIAL PROLIFERATION AND INHIBITS DIFFERENTIATION IN SMALL INTESTINE DEVELOPMENT. In GASTROENTEROLOGY Vol. 158 (pp. S87). Austin, TX: W B SAUNDERS CO-ELSEVIER INC. |
| 2017 | Whitehall, V., Bond, C., Liu, C., Kawamata, F., McKeone, D., Jamieson, S., . . . Leggett, B. (2017). Oncogenic <i>BRAF</i> mutation induces widespread DNA hypermethylation in a murine model for human serrated colorectal neoplasia. In CANCER RESEARCH Vol. 77 (pp. 2 pages). DC, Washington: AMER ASSOC CANCER RESEARCH. DOI |
| 2016 | Lannagan, T., Woods, S., Vrbanac, L., Yang, M., Ng, J., Wang, T., . . . Worthley, D. L. (2016). Desmoplasia stem and progenitor cells within the tumor microenvironment. In CANCER RESEARCH Vol. 76 (pp. 3 pages). LA, New Orleans: AMER ASSOC CANCER RESEARCH. DOI |
| 2016 | Lannagan, T. R. M., Mano, M. T., Head, R. J., Lockett, T., Ernst, M., & Cosgrove, L. J. (2016). DNA damage and tumour burden in mouse colon is increased in response to carcinogen exposure after induction of chronic inflammation - a more disease relevant model of colitis-associated colorectal cancer. In CANCER RESEARCH Vol. 76 (pp. 3 pages). New Orleans, LA: AMER ASSOC CANCER RESEARCH. DOI WoS1 |
| 2011 | Lannagan, T. R. M., Wilson, M. R., Battersby, S., Denison, F. C., Norman, J. E., Bennett, P. R., . . . Jabbour, H. N. (2011). The Mouse and the Membranes: A Role for Prokineticins in Infection-Induced Preterm Labor. In REPRODUCTIVE SCIENCES Vol. 18 (pp. 265A). SAGE PUBLICATIONS INC. |
| 2007 | Lannagan, T., Price, D., & Spears, N. (2007). Immune-like response in the developing mouse ovary.. In BIOLOGY OF REPRODUCTION (pp. 123). TX, San Antonio: SOC STUDY REPRODUCTION. |
| 2004 | Murray, A., Lannagan, T., Kind, P., & Spears, N. (2004). Investigation of the effect of PLC-β1 in mouse reproduction. In BIOLOGY OF REPRODUCTION (pp. 146). CANADA, Univ British Columbia, Vancouver: SOC STUDY REPRODUCTION. |
| Year | Citation |
|---|---|
| 2017 | Woods, S. L., Lannagan, T. R. M., Suzuki, N., Yang, M., Lee, Y. K., Wang, T., . . . Worthley, D. L. (2017). Bridging the GAPP between the laboratory and clinic to prevent gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS). Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY. |
| 2017 | Lannagan, T. R. M., Woods, S. L., Wang, T., Somashekar, R., Yang, M., Ng, J. Q., . . . Worthley, D. L. (2017). Gremlin 1-expressing intestinal reticular stem cells give rise to cancer-associated fibroblasts in a mouse model of colorectal cancer. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY. |
| 2017 | Lannagan, T. R. M., Lee, Y. K., Gieniec, K., Wang, T., Somashekar, R., Yang, M., . . . Woods, S. L. (2017). The development of a state-of the art, high-sensitivity stool DNA test to improve screening for serrated polyps and early lesions. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY. |
| Date | Role | Research Topic | Program | Degree Type | Student Load | Student Name |
|---|---|---|---|---|---|---|
| 2025 | Co-Supervisor | Enhancing T cell anti-tumour activity | Doctor of Philosophy | Doctorate | Full Time | Mr Wuyu Lin |
| Date | Role | Committee | Institution | Country |
|---|---|---|---|---|
| 2025 - ongoing | Member | SAiGENCI Postdoctoral Committee | SAiGENCI | Australia |
Connect With Me
External Profiles
